CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 4 Open-market buy Pres&Co-Head Bausch&Lomb/Int'l bought 25,440 shares at $22.96 ($584,018)
- 4 Grant or award Director acquired 5,832 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP AND GENERAL COUNSEL sold 19,946 shares at an average $24.98 ($498,302)
- 4 Grant or award Director acquired 1,217 shares (grant or award)
- 4 Grant or award Director acquired 1,460 shares (grant or award)
- 4 Grant or award Director acquired 1,071 shares (grant or award)
- 4 Grant or award Director acquired 1,217 shares (grant or award)
- 4/A Shares withheld for taxes Pres&Co-Head Bausch&Lomb/Int'l gave up 6,604 shares (to pay taxes)
- 4 Open-market buy Director bought 125,000 shares at $23.96 ($2,995,000)
- 4 Open-market buy EVP and CFO bought 10,000 shares at $22.61 ($226,100)
- 4 Open-market buy CHAIRMAN & CEO bought 30,000 shares at $22.32 ($669,600)
- 4 Shares withheld for taxes EVP and CFO gave up 24,626 shares (to pay taxes)
- 4 Shares withheld for taxes Pres&Co-Head Bausch&Lomb/Int'l gave up 5,501 shares (to pay taxes)
- 4 Shares withheld for taxes EVP AND GENERAL COUNSEL gave up 7,779 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $21.80 ($218,000)
- 4 Grant or award Director acquired 1,183 shares (grant or award)
- 4 Grant or award Director acquired 1,613 shares (grant or award)
Page 24 of 61 · 1,214 filings